NEW research employing Mendelian randomisation (MR) analysis has identified a potential causal relationship between lipid ...

Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...

Regulatory News: ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), next-generation biopharma dedicated to the ...

Scientists at Ohio University have identified a protein that could help fight obesity by improving metabolism and preventing ...

Regulatory News: ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), a next generation biopharma company dedicated to ...

A medical expert explained the non-pharmaceutical ways to lower cholesterol levels after a patient said they didn't like the ...

Neurofilament light chain and glial fibrillary acidic protein level increases were associated with cognitive decline in T2D with obesity.

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

A new study found 16 new genes that are likely linked to Alzheimer's risk. Here's everything to know about the study plus ...

A new study published in the Journal of American Medical Association showed that the innovative small interfering RNA (siRNA) medication olpasiran (Amgen) can effectively reduce lipoprotein(a) ...

Higher levels of environmental metals in urine are linked to worse cognitive performance and a greater risk of developing dementia.

In addition, the company develops Eplontersen to degrade mutant and wild-type TTR mRNA through binding to the TTR mRNA; Pelacarsen to inhibit the production of apolipoprotein(a) in the liver to ...